Ranbaxy Pleads Guilty, Pays $500M To Settle Federal Adulterated Drug Investigation

BALTIMORE - The American subsidiary of Indian drug maker Ranbaxy Laboratories Ltd. on May 13 agreed to pay $500 million in criminal fines and civil penalties and to plead guilty to seven counts of making adulterated prescription drugs, filing false statements ...read more